Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, Nicholas C.P. Cross. Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. haematol [Internet]. 2013Feb.28 [cited 2024Apr.28];98(3):404-8. Available from: https://haematologica.org/article/view/6591